Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 4 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Mar 2026, Jun 2026 and Sep 2026.
- Largest single sale: $3.9M (12,729 shares) of Krystal Biotech, Inc. on Jun 4, 2026. Filing
- Last sale before this period: Jul 16, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | President, R&D, Director | Sep 19, 2017 | Sep 4, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 4, 2026, Krystal Biotech, Inc.: sold 25,000 shares for $9.0M, under a disclosed plan. 1 filing: 1
- Jun 4, 2026, Krystal Biotech, Inc.: sold 25,000 shares for $7.7M, under a disclosed plan. 1 filing: 1
- Mar 4, 2026, Krystal Biotech, Inc.: sold 25,000 shares for $6.6M, under a disclosed plan. 1 filing: 1
- Feb 27, 2026, Krystal Biotech, Inc.: 26,500 shares vested; 30,584 shares withheld by the company for taxes; 40,725 shares vested or acquired by exercising options (some held indirectly). 1 filing: 1
- Dec 5, 2025, Krystal Biotech, Inc.: 5,000 shares given away (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.